pocketful logo
Aarey Drugs & Pharmaceuticals Ltd logo

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS BSE: 524412

₹69.28

(3.48%)

Mon, 30 Mar 2026, 04:40 am

mtf coin illustrationMTF 5x

Aarey Drugs & Pharmaceuticals PE Ratio

D/EEVEV/EBITDAP/BP/CFP/EP/SROE %
Particulars20082009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio19.0317.9614.5968.2439.8717.1921.3836.9533.5520.4010.335.378.3315.2115.9324.2423.67
Price to book ratio1.761.580.530.580.780.530.661.303.741.570.780.340.550.850.510.940.69
Price to sales ratio0.540.310.180.150.150.090.110.190.460.360.190.100.160.200.140.290.20
Price to cash flow ratio488.2900011.21013.2293.24433.7600018.7342.3500106.48
Enterprise value158.58M190.23M144.41M224.16M304.98M229.58M341M607.51M1.93B1.26B833.68M484.86M716.2M1.14B966.81M1.42B1.27B
Enterprise value to EBITDA ratio11.6014.509.8013.8914.7216.8824.5558.1419.9815.7910.5414.9314.958.268.7714.9214.96
Debt to equity ratio0.180.500.150.140.150.170.310.400.210.040.190.190.180.120.320.240.25
Return on equity %09.215.081.041.993.093.113.5812.759.467.846.486.816.173.263.742.97

Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio

The Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio is a key financial metric used by investors to evaluate Aarey Drugs & Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Aarey Drugs & Pharmaceuticals Ltd (NSE: AAREYDRUGS, BSE: 524412) is currently trading at ₹69.28, with a market capitalization of ₹1.95B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio is essential for fundamental analysis.

Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio Current Value

The current Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio stands at 23.67.

The Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio Historical Trend

The Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio has shown the following historical trend:

  • 2024: 23.67
  • 2023: 24.24
  • 2022: 15.93
  • 2021: 15.21
  • 2020: 8.33

The decline in Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio indicates improving financial efficiency or better earnings growth.

What Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio Indicates for Investors

The Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio plays a crucial role in understanding the company's financial health and valuation.

A higher P/E ratio indicates investors expect strong future earnings growth, while a lower ratio may signal undervaluation.

Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio Analysis Summary

The Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Aarey Drugs & Pharmaceuticals Ltd Price to Earnings Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800